Clinical trialNCT01071707CompletedObservational

Correlating Outcomes With Biochemical Markers to Estimate Time-progression in Idiopathic Pulmonary Fibrosis (IPF)

SponsorUniversity of MichiganEnrollment108Idiopathic Pulmonary Fibrosis

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Study purpose: The disease course of idiopathic pulmonary fibrosis (IPF) is variable. During the course of the disease some patients will get better, some will stay the same, and others will get worse. Currently doctors do not have any way to predict an individual patients disease course. The purpose of this study is to determine if 'biomarkers' such as proteins or genes isolated at the time of diagnosis can be used to predict the disease course. These 'biomarkers' will be obtained from samples of blood, from a procedure call a bronchoscopy, and in some patients from extra tissue obtained by a surgical lung biopsy.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Fernando J Martinez, MD,MS
University of Michigan
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗
Galen B Toews, MD
University of Michigan
Principal Investigator
clinicaltrials.gov ↗
Herbert Reynolds, MD
National Heart, Lung and Blood Institute, Division of Lung Sciences, National Institute of Health
Study Director
clinicaltrials.gov ↗
Kevin R Flaherty, MD, MS
University of Michigan
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

University of California, Los Angeles
Los Angeles, California, United States
University of California, San Francisco
San Francisco, California, United States
National Jewish Medical and Research Center
Denver, Colorado, United States
University of Chicago
Chicago, Illinois, United States
University of Michigan
Ann Arbor, Michigan, United States
Cleveland Clinic Foundation
Cleveland, Ohio, United States
Temple University
Philadelphia, Pennsylvania, United States
Brown University
Providence, Rhode Island, United States
Vanderbilt University
Nashville, Tennessee, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Dec 2009
Primary completion: 31 Aug 2011
Completion: 31 Aug 2012
Last update posted: 17 Oct 2012
Registered enrollment: 108
Registry id: NCT01071707

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.